ERCC1 and cancer: Results show that doxycycline treatment at 50 mg/kg was capable of regulating ERCC1 overexpression in vivo (Figure 5A,B), thus confirming the successful establishment of an animal model for precise ectopic cancer ERCC1 regulation.